KROS Operating Expenses

Keros Therapeutics Inc · Operating Expenses

KROS logo

KROS Operating Expenses

Latest reported$30.94M
KROS Quarterly Operating Expenses ($5.36M → $30.94M)
High-resolution chart · PNG

KROS operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Keros Therapeutics Inc Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
30,937,000
25,841,000
29,655,000
29,251,000
57,615,000
59,206,000
55,964,000
58,731,000
50,476,000
48,566,000
46,598,000
42,737,000
41,337,000
38,869,000
31,960,000
27,976,000
30,728,000
24,126,000
24,564,000
20,197,000
5,658,000
15,769,000
13,291,000
11,948,000
10,914,000
10,504,000
5,228,000
4,826,000
5,151,000
5,358,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.